No description
-
2013 (v1)PublicationUploaded on: April 14, 2023
-
2003 (v1)Publication
No description
Uploaded on: March 31, 2023 -
2013 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2013 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2013 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2014 (v1)Publication
INTRODUCTION: Ivabradine is a new heart-rate-lowering drug; the aim of this review was to analyze its role in heart failure (HF). AREAS COVERED: This systematic review on the role of ivabradine in HF is based on material searched and obtained through Pubmed and Medline up to September 2013. EXPERT OPINION: Heart rate (HR) is a risk factor in...
Uploaded on: April 14, 2023 -
2014 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2013 (v1)Publication
The aim of this literature review is to provide a better understanding of the available diagnostic modalities and interventional and pharmacological treatment options in the management of pregnant patients with acute myocardial infarction in order to improve the overall care provision and ensure both maternal and fe- tal well-being.
Uploaded on: April 14, 2023 -
2011 (v1)Publication
No description
Uploaded on: March 31, 2023 -
2016 (v1)Publication
No description
Uploaded on: March 27, 2023 -
2016 (v1)Publication
BACKGROUND: Intracardiac myxomas are frequent benign tumors of the heart and typically localize in the left atri- um and interatrial septum. When myxomas generate at other sites, they are designated as atypical. Mutations in the PRKAR1A gene (a tumor suppressor gene that encodes a protein kinase A [PKA] regulatory 1-alpha subunit) have been...
Uploaded on: April 14, 2023 -
2013 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2014 (v1)Publication
No description
Uploaded on: April 14, 2023